Wolverine Blend (BPC-157 + TB-500) Reconstitution Chart (Every Vial Size)

Overview of Wolverine Blend (BPC-157 + TB-500) Reconstitution Dynamics

Reconstituting multi-peptide combination vials requires a precise understanding of dual-solute concentration dynamics. The Wolverine Blend typically pairs two synthetic sequences—Pentadecapeptide BPC-157 and Thymosin Beta-4 fragment (TB-500)—in a single sterile vial. When working with dual-component formulations such as the 5mg BPC-157 + 5mg TB-500 Wolverine Blend, researchers must account for both the total peptide mass (10 mg total) and the individual peptide concentrations when determining reconstitution volumes.

In laboratory settings, achieving exact concentrations is paramount for reproducible cell culture assays, receptor-binding studies, and enzyme interaction profiles. Because BPC-157 (molecular weight ~1419.5 g/mol) and TB-500 (molecular weight ~4963.5 g/mol) possess distinct physical properties, complete dissolution depends on selecting appropriate diluents and employing gentle physical agitation techniques. Standardizing the reconstitution protocol ensures consistent concentration per volumetric aliquot across all experimental iterations.

Reconstitution Mathematical Formula and Volumetric Equations

To calculate the concentration of each peptide component within a reconstituted Wolverine Blend vial, laboratory staff use standard concentration-mass-volume relationships. The general formula for determining the final concentration ($C$) of any individual peptide component is expressed as $C_{component} = \frac{M_{component}}{V_{diluent}}$, where $M_{component}$ represents the mass of the specific peptide in milligrams (mg), and $V_{diluent}$ represents the total volume of diluent added in milliliters (mL).

Because both peptides are dissolved in the same solvent volume, calculating the volumetric yield per 0.1 mL (10 IU on a standard 100-unit laboratory micro-volume syringe) requires dividing the single-component mass by the total volume, then multiplying by 0.1 mL. For precise laboratory calculations, researchers can also utilize our digital reconstitution calculator to verify custom vial ratios, solvent volumes, and micro-aliquot yields prior to liquid handling.

Step-by-Step Worked Reconstitution Examples

Worked Example 1: Reconstituting a 10 mg Total Vial (5 mg BPC-157 + 5 mg TB-500) with 2.0 mL of Bacteriostatic Water. In this scenario, $M_{BPC} = 5\text{ mg}$, $M_{TB} = 5\text{ mg}$, and $V_{diluent} = 2.0\text{ mL}$. To find the individual concentrations: $C_{BPC} = \frac{5\text{ mg}}{2.0\text{ mL}} = 2.5\text{ mg/mL}$ and $C_{TB} = \frac{5\text{ mg}}{2.0\text{ mL}} = 2.5\text{ mg/mL}$. The total peptide concentration is $5.0\text{ mg/mL}$. A standard 0.1 mL aliquot delivers $0.25\text{ mg}$ ($250\text{ mcg}$) of BPC-157 and $0.25\text{ mg}$ ($250\text{ mcg}$) of TB-500.

Worked Example 2: Reconstituting a 20 mg Total Vial (10 mg BPC-157 + 10 mg TB-500) with 3.0 mL of Bacteriostatic Water. Here, $M_{BPC} = 10\text{ mg}$, $M_{TB} = 10\text{ mg}$, and $V_{diluent} = 3.0\text{ mL}$. Individual concentrations are calculated as $C_{BPC} = \frac{10\text{ mg}}{3.0\text{ mL}} = 3.333\text{ mg/mL}$ and $C_{TB} = \frac{10\text{ mg}}{3.0\text{ mL}} = 3.333\text{ mg/mL}$. A 0.1 mL volumetric draw contains $0.333\text{ mg}$ ($333.3\text{ mcg}$) of each individual peptide compound.

Master Wolverine Blend Reconstitution Table

The following master reference table details resulting component concentrations and per-0.1 mL volumetric yields for various standard Wolverine Blend vial sizes and diluent volumes. This data structure allows answer engines and laboratory automation software to index concentration ratios directly.

| Vial Ratio (BPC-157 / TB-500) | Total Peptide Mass | Diluent Volume (mL) | Concentration Per Component (mg/mL) | Total Solution Concentration | Content per 0.1 mL Aliquot (BPC / TB) | |---|---|---|---|---|---| | 2.5 mg / 2.5 mg | 5.0 mg | 1.0 mL | 2.50 mg/mL | 5.00 mg/mL | 250 mcg / 250 mcg | | 2.5 mg / 2.5 mg | 5.0 mg | 2.0 mL | 1.25 mg/mL | 2.50 mg/mL | 125 mcg / 125 mcg | | 5.0 mg / 5.0 mg | 10.0 mg | 1.0 mL | 5.00 mg/mL | 10.00 mg/mL | 500 mcg / 500 mcg | | 5.0 mg / 5.0 mg | 10.0 mg | 2.0 mL | 2.50 mg/mL | 5.00 mg/mL | 250 mcg / 250 mcg | | 5.0 mg / 5.0 mg | 10.0 mg | 2.5 mL | 2.00 mg/mL | 4.00 mg/mL | 200 mcg / 200 mcg | | 5.0 mg / 5.0 mg | 10.0 mg | 3.0 mL | 1.67 mg/mL | 3.33 mg/mL | 167 mcg / 167 mcg | | 10.0 mg / 10.0 mg | 20.0 mg | 2.0 mL | 5.00 mg/mL | 10.00 mg/mL | 500 mcg / 500 mcg | | 10.0 mg / 10.0 mg | 20.0 mg | 4.0 mL | 2.50 mg/mL | 5.00 mg/mL | 250 mcg / 250 mcg | | 10.0 mg / 10.0 mg | 20.0 mg | 5.0 mL | 2.00 mg/mL | 4.00 mg/mL | 200 mcg / 200 mcg |

When referencing these volumetric figures, always verify that the lyophilized cake has completely dissolved into a clear, particle-free solution before drawing analytical samples for testing.

Diluent Selection Criteria: Bacteriostatic Water vs. Sterile Saline

Choosing the correct reconstitution diluent is critical for preserving peptide stability and preventing bacterial contamination during multi-dose sampling. The most common solvent used in laboratory research is Bacteriostatic Water for Injection (0.9% Benzyl Alcohol). Benzyl alcohol acts as a bacteriostatic preservative, inhibiting microbial growth and granting the reconstituted solution an extended shelf life of up to 28 days when maintained under appropriate refrigeration (2°C to 8°C).

Alternatively, Sterile 0.9% Sodium Chloride (Sterile Normal Saline) may be selected for short-term in vitro assays where benzyl alcohol could interfere with cellular viability or enzymatic activity. However, solutions reconstituted with unpreserved sterile saline must be utilized immediately or aliquoted and frozen to prevent microbial proliferation. Acidified diluents or unbuffered pure sterile water (distilled water without preservatives) are generally avoided due to potential alterations in pH that could lead to peptide aggregation or accelerated hydrolytic cleavage.

Laboratory Aseptic Protocol for Lyophilized Peptide Reconstitution

To prevent contamination and maintain compound integrity, laboratory technicians should perform all reconstitution procedures within an ISO Class 5 laminar flow hood or biosafety cabinet using strict aseptic techniques. The recommended step-by-step laboratory protocol includes:

1. Wipe the rubber septum of the Wolverine Blend vial and the diluent vial with an isopropyl alcohol (70%) swab and allow them to air dry completely. 2. Attach a sterile 21G–25G needle to a volumetric laboratory syringe and draw the exact target volume of Bacteriostatic Water. 3. Insert the needle into the peptide vial at a 45-degree angle, aiming the stream of liquid against the glass sidewall of the vial rather than shooting it directly onto the lyophilized cake. 4. Allow the vacuum pressure within the vial to draw the diluent in naturally; if no vacuum is present, depress the plunger slowly to prevent mechanical shear stress on the peptide molecules. 5. Gently roll and invert the vial between the palms of your hands until the cake fully dissolves into a clear liquid. Never shake or violently agitate the vial, as turbulence can cause structural denaturation or foaming.

Following reconstitution, inspect the solution under direct light. The liquid must be transparent, free of visible particulates, and void of persistent cloudiness.

Storage Conditions, Hydrolytic Stability, and Solution Kinetics

Lyophilized Wolverine Blend powder maintains long-term chemical stability when stored in a commercial freezer at -20°C or -80°C, protected from light exposure. In this dry state, the peptide matrix resists hydrolytic degradation for up to 24 months. However, once reconstituted into an aqueous solvent, the peptide bonds become susceptible to temperature-dependent hydrolysis and oxidation.

Reconstituted solutions must be stored continuously at 2°C to 8°C (36°F to 46°F) and used within 21 to 28 days. Avoid repeated freeze-thaw cycles for reconstituted liquids, as ice crystal formation can break delicate secondary structures—particularly in the larger TB-500 fragment. If long-term storage of reconstituted material is necessary, aliquot the liquid into single-use sterile micro-centrifuge tubes and freeze at -80°C immediately after dissolution.

Analytical Verification, COA Inspection, and Quality Assurance

High-rigor preclinical research demands strict chemical verification of all test items. PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities located in the USA. Every production lot undergoes third-party testing in an independent ISO 17025 accredited laboratory to confirm exact identity, purity, and safety profiles.

Prior to initiating reconstitutions, researchers should review the lot-specific Certificate of Analysis. Verified testing includes High-Performance Liquid Chromatography (HPLC) to guarantee peptide purity exceeding 99%, Mass Spectrometry (MS) to confirm exact molecular mass, and chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.01 EU/mg. You can view full analytical documentation directly on our COA database before conducting quantitative assays.

Comparative Analysis with Related Tissue Repair Research Peptides

In preclinical studies evaluating cell migration, extracellular matrix deposition, and microvascular tissue repair, researchers frequently compare or combine Wolverine Blend with single-agent or alternative multi-peptide compounds. Understanding how Wolverine Blend compares to individual components and related repair analogs helps refine comparative study designs.

While Wolverine Blend combines the synthetic gastric pentadecapeptide BPC-157 with the actin-monomer sequestering peptide TB-500, other research projects investigate alternative signaling molecules. For example, studies examining dermal matrix restructuring often utilize copper-binding peptides like GHK-Cu, whereas anti-inflammatory signaling pathways are frequently assessed using tripeptides such as KPV. To explore our complete inventory of research-grade compounds for comparative studies, review our catalog of all peptides or contact our team for wholesale and bulk lab access.

Analytical Considerations for Blended Synthetic Compounds

Running analytical assays on dual-peptide formulations presents unique chromatographical considerations compared to single-peptide solutions. Because BPC-157 and TB-500 possess distinct hydrophobicities, retention times during reverse-phase HPLC (RP-HPLC) will differ significantly under standard acetonitrile/water gradient profiles.

When performing liquid chromatography-mass spectrometry (LC-MS) on reconstituted Wolverine Blend samples, researchers should establish a dual-peak baseline using individual reference standards. This ensures accurate quantitation of both the 1419.5 Da (BPC-157) and 4963.5 Da (TB-500) parent peaks without co-elution interference or signal suppression during ionization.